Aflac (NYSE:AFL) PT Raised to $82.00 at Truist Financial

Aflac (NYSE:AFLGet Free Report) had its target price increased by equities research analysts at Truist Financial from $80.00 to $82.00 in a note issued to investors on Friday, Benzinga reports. The brokerage presently has a “hold” rating on the financial services provider’s stock. Truist Financial’s price objective suggests a potential downside of 1.45% from the stock’s current price.

Several other research firms have also weighed in on AFL. Wells Fargo & Company cut their target price on shares of Aflac from $83.00 to $81.00 and set an “equal weight” rating on the stock in a report on Thursday, April 11th. The Goldman Sachs Group boosted their price objective on Aflac from $61.00 to $75.00 and gave the company a “sell” rating in a research report on Tuesday, January 9th. UBS Group raised their target price on shares of Aflac from $80.00 to $84.00 and gave the stock a “neutral” rating in a report on Wednesday, January 10th. Piper Sandler increased their price objective on shares of Aflac from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Friday, April 5th. Finally, Keefe, Bruyette & Woods raised their price objective on shares of Aflac from $83.00 to $87.00 and gave the stock a “market perform” rating in a report on Wednesday, April 10th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, Aflac currently has a consensus rating of “Hold” and a consensus price target of $82.31.

Check Out Our Latest Research Report on AFL

Aflac Stock Down 1.0 %

NYSE:AFL opened at $83.21 on Friday. The stock’s fifty day simple moving average is $83.14 and its 200-day simple moving average is $81.89. The firm has a market capitalization of $47.88 billion, a P/E ratio of 9.18, a P/E/G ratio of 2.31 and a beta of 0.91. The company has a quick ratio of 0.06, a current ratio of 0.08 and a debt-to-equity ratio of 0.34. Aflac has a 12-month low of $64.10 and a 12-month high of $86.26.

Aflac (NYSE:AFLGet Free Report) last posted its earnings results on Wednesday, May 1st. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.58 by $0.08. The company had revenue of $5.44 billion during the quarter, compared to analyst estimates of $4.09 billion. Aflac had a return on equity of 16.88% and a net margin of 27.67%. The company’s revenue for the quarter was up 13.3% compared to the same quarter last year. During the same period in the previous year, the company earned $1.55 EPS. Equities research analysts expect that Aflac will post 6.41 earnings per share for the current year.

Insider Activity

In other news, Director Arthur Reginald Collins sold 3,000 shares of the company’s stock in a transaction dated Thursday, February 22nd. The shares were sold at an average price of $79.73, for a total value of $239,190.00. Following the sale, the director now directly owns 5,592 shares of the company’s stock, valued at approximately $445,850.16. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, Director Arthur Reginald Collins sold 3,000 shares of the business’s stock in a transaction that occurred on Thursday, February 22nd. The stock was sold at an average price of $79.73, for a total transaction of $239,190.00. Following the transaction, the director now directly owns 5,592 shares of the company’s stock, valued at approximately $445,850.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Thomas J. Kenny sold 5,000 shares of the firm’s stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $84.62, for a total value of $423,100.00. Following the sale, the director now directly owns 17,920 shares of the company’s stock, valued at approximately $1,516,390.40. The disclosure for this sale can be found here. Insiders sold a total of 46,493 shares of company stock valued at $3,765,706 in the last quarter. Company insiders own 0.90% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. grew its position in shares of Aflac by 1.1% in the third quarter. Vanguard Group Inc. now owns 54,208,007 shares of the financial services provider’s stock valued at $4,160,465,000 after purchasing an additional 605,210 shares during the last quarter. Morgan Stanley grew its holdings in Aflac by 9.0% in the 3rd quarter. Morgan Stanley now owns 9,643,531 shares of the financial services provider’s stock valued at $740,141,000 after buying an additional 794,784 shares in the last quarter. Northern Trust Corp increased its position in Aflac by 5.3% during the 3rd quarter. Northern Trust Corp now owns 7,295,810 shares of the financial services provider’s stock worth $559,953,000 after buying an additional 368,704 shares during the period. Invesco Ltd. lifted its holdings in shares of Aflac by 5.0% during the third quarter. Invesco Ltd. now owns 4,808,289 shares of the financial services provider’s stock worth $369,036,000 after buying an additional 227,516 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in Aflac by 0.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 3,190,954 shares of the financial services provider’s stock worth $263,254,000 after acquiring an additional 17,892 shares during the period. Institutional investors and hedge funds own 67.44% of the company’s stock.

About Aflac

(Get Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Featured Stories

Analyst Recommendations for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.